Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-25-012189
Filing Date
2025-02-11
Accepted
2025-02-11 16:00:49
Documents
47
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0229816-10q_pluri.htm   iXBRL 10-Q 568821
2 FORM OF RSU AND OPTIONS WAIVER LETTER AGREEMENT ea022981601ex10-4_pluri.htm EX-10.4 6372
3 CERTIFICATION ea022981601ex31-1_pluri.htm EX-31.1 9431
4 CERTIFICATION ea022981601ex31-2_pluri.htm EX-31.2 9551
5 CERTIFICATION ea022981601ex32-1_pluri.htm EX-32.1 3356
6 CERTIFICATION ea022981601ex32-2_pluri.htm EX-32.2 3447
7 GRAPHIC ex10-4_001.jpg GRAPHIC 11962
  Complete submission text file 0001213900-25-012189.txt   3462532

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE plur-20241231.xsd EX-101.SCH 26708
9 XBRL CALCULATION FILE plur-20241231_cal.xml EX-101.CAL 31971
10 XBRL DEFINITION FILE plur-20241231_def.xml EX-101.DEF 140963
11 XBRL LABEL FILE plur-20241231_lab.xml EX-101.LAB 299017
12 XBRL PRESENTATION FILE plur-20241231_pre.xml EX-101.PRE 155111
50 EXTRACTED XBRL INSTANCE DOCUMENT ea0229816-10q_pluri_htm.xml XML 321013
Mailing Address MATAM ADVANCED TECHNOLOGY PARK BUILDING NO. 5 HAIFA L3 3508409
Business Address MATAM ADVANCED TECHNOLOGY PARK BUILDING NO. 5 HAIFA L3 3508409 972-74-710-7171
Pluri Inc. (Filer) CIK: 0001158780 (see all company filings)

EIN.: 980351734 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-31392 | Film No.: 25609664
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)